SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001437749-12-011642
Filing Date
2012-11-14
Accepted
2012-11-14 10:56:59
Documents
11
Period of Report
2012-09-30
Filing Date Changed
2012-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gfr_10q-093012.htm 10-Q 877238
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 20259
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 21777
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5537
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5255
  Complete submission text file 0001437749-12-011642.txt   6243517

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE gfrp-20120930.xml EX-101.INS 1267151
7 XBRL TAXONOMY EXTENSION SCHEMA gfrp-20120930.xsd EX-101.SCH 41323
8 XBRL TAXONOMY EXTENSION CALCULATION gfrp-20120930_cal.xml EX-101.CAL 28575
9 XBRL TAXONOMY EXTENSION DEFINITION gfrp-20120930_def.xml EX-101.DEF 198201
10 XBRL TAXONOMY EXTENSION LABELS gfrp-20120930_lab.xml EX-101.LAB 254074
11 XBRL TAXONOMY EXTENSION PRESENTATION gfrp-20120930_pre.xml EX-101.PRE 202752
Mailing Address 9160 E. DEER TRAIL 9160 E. DEER TRAIL TUCSAN AZ 85710
Business Address SUITE 11405 - 201A STREET MAPLE RIDGE A1 V2X 0Y3 5205771516
GFR PHARMACEUTICALS INC (Filer) CIK: 0001096294 (see all company filings)

IRS No.: 770517964 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27959 | Film No.: 121201766
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1